The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma

Chemico-Biological Interactions

Volumn 161, Issue 1, 2006, Pages 69-78

  Veena, Krishnamurthy ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanatham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cholesterol; Emblica officinalis; Lipids; Mammary carcinoma; Semecarpus anacardium

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; CHOLESTEROL ESTERASE; ENZYME; FATTY ACID; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN; KALPAAMRUTHAA; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AYURVEDA; BREAST CARCINOMA; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; EMBLICA OFFICINALIS; ENZYME BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; HONEY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KIDNEY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER; MEDICINAL PLANT; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RAT; SEMECARPUS; SEMECARPUS ANACARDIUM; STOMACH INTUBATION; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BREAST NEOPLASMS; CARBOXYLIC ESTER HYDROLASES; FEMALE; KIDNEY; LIPID METABOLISM; LIVER; MEDICINE, AYURVEDIC; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEMECARPUS;

ANIMALIA; PHYLLANTHUS EMBLICA; SEMECARPUS; SEMECARPUS ANACARDIUM;

EID: 33646117496     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.03.003     Document Type: Article

References (54)

1. Baselga J., and Mendelsohn J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res. Treat. 29 (1994) 127-138
2. Kuhajda F.P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16 (2000) 202-208
3. Moncur J.T., Park J.P., Memoli V.A., Mohandas T.K., and Kinlaw W.B. The "Spot 14" gene resides on the telomeric end of the 11q13amplicon and is expressed in lipogenic breast cancers: implications for control of tumor metabolism. Proc. Natl. Acad. Sci. 95 (1998) 6989-6994
4. Pizer E.S., Jackisch C.H., Wood F.D., Pasternack G.R., Davidson E.N., and Kuhajda F.P. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56 (1996) 2745-2747
5. Watkins T., Lenz P., Gapor A., Struck M., Tomco A., and Biesenbaum M. Tocotrienol as a hypocholesterolic and antioxidant agent in rats fed atherogenic diet. Lipids 28 (1993) 1113-1118
6. Lane D.M., Bootman K.K., and McConatty W.J. Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res. Treat. 34 2 (1995) 161-169
7. Veena K., Shanthi P., and Sachdanandam P. Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal and marker enzymes. Biol. Pharm. Bull. 29 (2006) 565-569
8. Sathyavathi G.V., Prasad D.N., and Singh H.D. Anti-inflammatory activity of Semecarpus anacardium Linn. A preliminary study. Ind. J. Physiol. Pharmacol. 13 (1969) 37-43
9. Ramprasath V.R., Shanthi P., and Sachdanandam P. Evaluation of antioxidant effect of Semecarpus anacardium Linn. nut extract on the components of immune system in adjuvant arthritis. Vas. Pharmacol. 42 4 (2005) 179-186
10. Sujatha V., and Sachdanandam P. Recuperative effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats. Phytother. Res. 16 (2002) S14-S18
11. Premalatha B., Muthulakshmi V., Vijayalakshmi T., and Sachdanandam P. Protective role of Serankottai nei, A. Siddha preparation on cell membranes in aflatoxin B, insured hepatocellular carcinoma bearing rats. Indian Drugs 34 (1997) 384-389
12. Vijayalakshmi T., Muthulakshmi V., and Sachdanandam P. Effect of milk extract of Semecarpus anacardium nut on adjuvant arthritis - A dose dependent study in albino rats. Gen. Pharmacol. 27 7 (1996) 1223-1226
13. Godbole S.H., and Pendse G.S. Antibacterial property of some plants. Ind. J. Pharm. 22 (1960) 39-42
14. Asmawi M.Z., Kankaanranta H., Moilanen E., and Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn. leaf extracts. J. Pharm. Pharmacol. 45 (1993) 581-584
15. Dhir H., Roy R.K., Sharma A., and Talukdar G. Modification of clastogenicity of lead and aluminium in mouse bone marrow cells by dietary ingestion of Phyllanthus emblica fruit extract. Mutat. Res. 241 (1990) 305-312
16. Frei B. Reactive oxygen species and antioxidant vitamins: mechanism of action. Am. J. Med. 97 (1994) 5S-13S
17. Kotze J.P., Mathews M.J., and Klerk W.A. Effect of ascorbic acid on lipoprotein lipase activity. S. Afr. Med. J. 48 (1974) 511-514
18. Wollenweber E. Occurrence of flavonoid aglycones in medicinal plants. Prog. Clin. Biol. Res. 280 (1988) 45-55
19. Mitchell J.H., Gardner P.T., Mcphail D.B., Morrice P.C., Collins A.R., and Duthie G.G. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys. 360 (1998) 142-148
20. Welsch C.W. Factors affecting the growth of carcinogen induced rat mammary carcinomas. A review and tribute to Charles Brenton huggins. Cancer Res. 45 (1985) 3415-3443
21. Sujatha V., Muthumanickam V., Rani G., and Sachdanandam P. Effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in experimentally induced mammary carcinoma in rats. J. Pharm. Pharmacol. 51 (1999) 241
22. Folch J., Less M., and Stanely G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1951) 49-509
23. Parkeh A.C., and Jung D.H. Cholesterol determination with ferric chloride uranium acetate and sulphuric acid-ferrous sulphate reagents. Anal. Chem. 42 (1970) 1423-1427
24. Leffler H.H., and McDougald C.H. A colorimetric method for the estimation of cholesterol. Am. J. Clin. Pathol. 39 (1963) 311-313
25. Rouser G., Fleisher S., and Yamanoto A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by hosphorus analysis of spots. Lipids 5 (1970) 494-496
26. Rice E.W. Triglycerides in serum. In: Roderick P., and MacDonald C.H. (Eds). Standard Methods of Clinical Chemistry. 6th ed. (1970), Academic Press, New York 215-222
27. Van Handle E. Modification of the micro determinating triglycerides. Clin. Chem. 7 (1961) 249-251
28. Horn W.T., and Menahan L.A. A sensitive method for the determination of free fatty acids in plasma. J. Lipid Res. 22 (1981) 377-381
29. Bier M. Enzymes of lipid metabolism. Lipases and esterases. Meth. Enzymol. 1 (1955) 631-638
30. Schmidt A. Measurement of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma. Meth. Enzymol. 72 (1974) 325-337
31. Legraud A., Guillansseav R.J., Land J., et al. Method colorimetric simole determination del'activit., de la lecithin cholesterol acyl transferase (LCAT) Plasmatique. Interest on diabeteologic. In: Siest G., and Glateau M.M. (Eds). Biologic Prospective (1979), Masson, Paris 368-371
32. Hitz J., Sternmetz J., and Siest G. Plasma LCAT-reference values and effects of xenobiotics. Clin. Chim. Acta 133 (1983) 85-96
33. Kothari H.V., Bonner M.J., and Miller B.F. Cholesterol ester hydrolase in homogenates and lysosomal fractions of human aorta. Biochem. Biophys. Acta 202 (1970) 325-331
34. Kritchevsky D., and Kothari H.V. Aortic cholesterol esterase in rabbits. Effects of duration of cholesterol feeding. Biochem. Biophys. Acta 326 (1973) 489-491
35. Wilson D.E., and Spiger M.J. A dual precipitation method for quantitative lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med. 82 (1973) 473-483
36. Stepsenwol J. Carcinogenic effect of cholesterol in mice. Proc. Soc. Exp. Biol. Med. 121 (1966) 168-171
37. Damen J., Ramshorst J.V., Hoeven R.P.V., et al. Alterations in plasma lipoproteins and heparin releasable lipase activities in mice bearing the GRSL ascites tumour. Biochem. Biophys. Acta 793 (1984) 287-296
38. Dessi S., Batetta B., Anchisi C., Pani P., Costelli P., Tessitore L., and Baccino F.M. Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br. J. Cancer 66 (1992) 787-793
39. Kumar K., Sachdanandam P., and Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem. Int. 23 (1991) 581-589
40. Quarforat S.H., and Hilderman H.L. Quantitation of the in vitro free cholesterol exchange of human red cells and lipoproteins. J. Lipid Res. 11 (1970) 528-534
41. Basu T.K., and Williams D.C. Plasma and body lipids in patients with carcinoma of the breast. Oncology 31 (1975) 172-176
42. Rogers M.P., and Hutchinson I. The effect of in vitro high-density lipoprotein on hydrolysis of triacyl glycerol by lipoprotein lipase. Biochem. J. 200 (1981) 453-457
43. Krol W., Dworniczak S., Pietsz G., Czuba Z.P., Kunicka M., Kopacz M., and Nowak D. Synthesis and tumouricidal activity evaluation of new morin and quercetin sulfonic derivatives. Acta Pol. Pharm. 59 1 (2002) 77-79
44. Regnstrom J., Nisson J., Toruvall P., Laudou C., and Hamsten A. Susceptibility to low-density lipoproteins oxidation and coronary atherosclerosis in man. Lancet 339 (1992) 1883-1886
45. Chander R., and Kapoor N.K. High-density lipoprotein is a scavenger of superoxide anions. Biochem. Pharmacol. 40 (1990) 1663-1665
46. Carbo N., Costelli P., Tessitore L., et al. Anti-tumour necrosis factor treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin. Sci. 87 (1994) 349-355
47. Bain C., Willet W., Rosner B., et al. Early age at first birth and decreased risk of breast cancer. Am. J. Epidemiol. 114 (1981) 705-709
48. Fredrickson D.S., Goldstein J.L., and Brown M.S. In: Stanbury J.B., Wijngarden J.B., and Fredrikson D.S. (Eds). The Metabolic Basis of Inherited Disease (1978), McGraw-Hill, New York 604-655
49. Zlelinski C.C., Stuller I., Rausch P., and Muller C. Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer. J. Cancer Res. Clin. Oncol. 114 5 (1988) 514-518
50. Stavric B., and Matula T.I. Flavonoids in foods. Their significance for nutrition and health. In: Ong A.S.H., and Packer L. (Eds). Lipid Soluble Antioxidants Biochemistry and Clinical Applications (1992), Birkhauser Verlag, Basel, Switzerland 274-293
51. Yang C.S., Landau J.M., Huang M.-T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21 (2001) 381-406
52. Boersma B.J., Barnes S., Kirk M., Wang C.C., Smith M., Kimb H., Xub J., Patel R., and Darley-Usmar V.M. Soy isoflavonoids and cancer - metabolism at the target site. Mutat. Res. 480-481 (2001) 121-127
53. Bendich A. Vitamin C safety in humans. In: Packer L., and Fuchs J. (Eds). Vitamin C in Health, and Disease (1997), Marcel-Dekker Inc., New York 367-379
54. Nunez M.C., and Ortiz de Apodaca y Ruiz A. Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of the consumption of food with an elevated content of this vitamin. Nutr. Hosp. 10 (1995) 368-372